13774214275
13774214275
產品中心
當前位置：首頁
產品中心抗體/抗原Biosimilar抗體S0B0558Anti-EGFR Monoclonal Antibody(Cetuximab)
產品型號：S0B0558
更新時間：2025-10-10
廠商性質：生產廠家
訪問量：98
服務熱線15855403091
相關文章
Cetuximab is a monoclonal antibody that inhibits the epidermal growth factor receptor （EGFR） which is present on the surface of some cancer cells. Cetuximab binds to the receptor, preventing epidermal growth factor （EGF） from binding to it and stimulating growth of the cancer cells. Cetuximab is used to treat squamous cell cancer of the head and neck. Cetuximab is commonly used alongside chemotherapy as a first line approach to cancer that has spread or is recurring. It is also used alongside radiation therapy in localized disease. Patients with metastatic colorectal cancer that expresses EGFR may be treated with cetuximab in combination with chemotherapy or cetuximab may be given as a single therapy to patients who have failed to respond to irinotecan- and oxaliplatin-based regimens.
上一個：
返回列表
